Weyer Christian 4
4 · INTERCEPT PHARMACEUTICALS, INC. · Filed Apr 29, 2020
Insider Transaction Report
Form 4
Weyer Christian
EVP Research and Development
Transactions
- Sale
Common Stock
2020-04-27$85.95/sh−181$15,557→ 17,140 total
Footnotes (1)
- [F1]This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person.